Eikon Therapeutics $381 million IPO
We advised the representatives of the several underwriters on the IPO
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Maze Therapeutics $200 million at-the-market offering
We advised the sales agent on the offering
Perspective Therapeutics $175 million equity offering
We advised the representatives of the underwriters on the transaction
Roche Holdings $1.9 billion notes offering
We advised Roche on the offering comprising three tranches of notes
bit.bio $50 million Series C equity financing
We are advising the company on the funding round
Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026
Beacon Therapeutics $75 million Series C financing round
We advised Forbion on its participation in the financing round
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
PegBio HK$300 million placement of shares
We advised PegBio on the placement of new shares
Kodiak Sciences $184 million stock offering
We advised the underwriters on the offering